A new study describes a technique that rejuvenates aging blood-forming stem cells and could help reduce the risk of age-related blood disorders.

In a mouse study, blood stem cells from sickle cell disease (SCD) patients modified with CRISPR/Cas9 gene editing showed reduced long-term contribution compared with cells treated using other ...

Every year, millions of lives are suddenly, swiftly transformed by a stroke, which occurs when a blood vessel travelling towards the brain becomes obstructed, causing neurons to die off. Strokes are ...

Gene therapies for beta thalassemia and sickle cell disease face limited uptake due to high costs, affecting biotech companies' business prospects. Lyfgenia's uptake has been faster than Zynteglo's, ...

Casgevy gene therapy shows promise in treating young children with sickle cell disease and beta thalassemia, improving transfusion independence and reducing vaso-occlusive crises. A fatality due to ...

Oliver Chu has shown “dramatic improvements” following the groundbreaking treatment, his father Ricky Chu said The University of Manchester (MFT) Oliver Chu, 3, was born with a rare genetic condition ...

A three-year-old Oliver (Ollie) Chu has become the world’s first patient to receive a revolutionary stem cell gene therapy for Hunter syndrome. This rare, progressive, inherited disorder damages the ...

A three-year-old boy from California has become the first patient with Hunter syndrome to receive an experimental gene therapy developed in Manchester, marking a potential advance for treating the ...

The special properties of methylcellulose foam could make it a vehicle for bedside genetic engineering, according to a proof-of-principle study from bioengineers at Fred Hutch Cancer Center. In the ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Longevity and disease resistance in humans may soon be ...